General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Huber AM – Current treatment is with corticosteroids, frequently in combination with other medications such as methotrexate or intravenous gammaglobulin. Newer therapies, such as anti–tumor necrosis factor agents and rituximab are currently being evaluated; it is not clear what role these medications will have in the future.

Related Articles

Dermatomyositis and HIV infection: case report and review of the literature
Rheumatology International, 11/16/09    Relevance Score: 90%

A histopathologic study of mechanics hands associated with dermatomyositis: a report of five cases
International Journal of Dermatology, 10/28/09    Relevance Score: 85%

Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
Best Practice & Research: Clinical Rheumatology, 10/28/09    Relevance Score: 85%

Dermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09    Relevance Score: 85%

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis
Scandinavian Journal of Rheumatology, 10/08/09    Relevance Score: 85%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address